Join the 200th Anniversary Celebration

Perspective

Nonpayment for Performance? Medicare's New Reimbursement Rule

Meredith B. Rosenthal, Ph.D.

N Engl J Med 2007; 357:1573-1575October 18, 2007

Article

Audio Interview

Interview with Meredith Rosenthal on Medicare’s decision to stop reimbursing hospitals for some of the care made necessary by improper care.

Interview with Meredith Rosenthal on Medicare’s decision to stop reimbursing hospitals for some of the care made necessary by improper care. (7:14)

To defuse physicians' and hospitals' opposition to the creation of Medicare back in 1965, the program's congressional architects selected payment mechanisms designed to preserve the status quo.1 But as Medicare has expanded and problems of affordability and quality of care have grown, such an approach has become untenable. Recently, the Centers for Medicare and Medicaid Services (CMS) announced its decision to cease paying hospitals for some of the care made necessary by “preventable complications” — conditions that result from medical errors or improper care and that can reasonably be expected to be averted. This rule, which implements a congressionally mandated change in hospital reimbursement, is the latest in a series of steps that have rendered Medicare's payment policy far less passive than it once was.2

The starting point for current Medicare payments for inpatient care is the system based on diagnosis-related groups (DRGs) that was adopted in 1983 by CMS's predecessor, the Health Care Financing Administration. That system is considered prospective, in that the amount paid to a hospital for a patient is fixed in advance and depends only on the diagnoses and major procedures reported at discharge (which, in turn, map to a specific DRG).

In reality, payments under this system have never been completely prospective, being influenced to some degree by what happens to an individual patient during a hospitalization. For example, higher payments are made on behalf of patients in whom clinically significant complications develop after admission than for those with the same diagnosis who have no such complications. There are also so-called outlier payments that partially compensate hospitals for the additional expenses incurred for very-high-cost cases. With regard to preventable complications, these retrospective features of the DRG payment system have harbored a perverse incentive: hospitals that improved patient safety and ameliorated problems such as nosocomial infections saw their Medicare revenues — and sometimes their profits — reduced.

Believing that this counterproductive incentive should be eliminated, Congress instructed the Secretary of Health and Human Services in 2005 to “select at least 2 conditions that are (a) high cost or high volume or both, (b) result in the assignment of a case to a DRG that has a higher payment when present as a secondary diagnosis, and (c) could reasonably have been prevented through the application of evidence-based guidelines.”2 After issuing a proposed set of measures and considering comments from stakeholders and experts, CMS decided to disallow incremental payments associated with eight secondary conditions that it sees as preventable complications of medical care (see tableConditions for Which Medicare Will No Longer Pay More If Acquired during an Inpatient Stay.).2 These conditions, if not present at the time of admission, will no longer be taken into account in calculating payments to hospitals after October 1, 2008.

The new rule will result in hospitals seeing substantial reductions in payment for the care of individual patients with preventable complications. For example, if a patient were admitted to a Boston-area hospital with pneumonia and developed a urinary tract infection or bed sores during the hospitalization, the hospital would currently be paid $6,253.58, under DRG 89 (“pneumonia with complications”); under the new rule, if there were no other complications, the hospital would be paid only $3,705.38, under DRG 90 (“simple pneumonia”) — a difference of $2,548.20 (a reduction of approximately 40%). The policy, however, is unlikely to change the total Medicare payments to hospitals substantially, because the payment will be “reduced” only for instances in which preventable complications were the only factors causing a case to be reclassified under a more expensive DRG.

Medicare will continue to make outlier payments for cases with costs substantially exceeding the average for the appropriate DRG, even when these costs are the consequence of preventable complications — and the likelihood of incurring such outlier payments will actually be increased by the new policy, because cases in which there are complications will more easily exceed the threshold associated with the lower-paying DRG. Moreover, preventable complications including the eight that CMS identified for exclusion may continue to result in higher Medicare payments to hospitals, because their downstream consequences may place cases in entirely different and very-high-cost DRGs, such as DRG 483 (tracheostomy with mechanical ventilation for 96 hours or more). The new approach does not attempt to unravel these more complex clinical scenarios.

Although in the near term, the amount of money withheld may be small, in terms of the percentage of all payments to hospitals, it can be expected to have a disproportionate effect on their behavior. One reason is that this change represents the leading edge of a series of anticipated CMS reforms of provider payment, which include a shift toward pay for performance. Hospitals may therefore view the new policy as a harbinger of things to come and act in anticipation of more substantial reimbursement changes. In addition, nonreimbursement for costs associated with perceived quality failings may be a more powerful motivator than an equal reward for eliminating complications.3 Finally, because hospitals will be obliged to ascertain and code infections and other conditions as “present on admission” to avoid reductions in their revenues, the policy may lead to more widespread adoption of quality measurement and reporting or to improved targeting of prophylaxis against or treatment of community-acquired infections.

During its development, the new rule was criticized both for going too far and for not going far enough. Some stakeholders argued that it will penalize hospitals for treating frail or otherwise high-risk patients, encouraging them to avoid such patients. Although this concern may be valid, the new rule only exacerbates an inherent side effect of prospective payment in the absence of perfect risk adjustment: to the extent that certain observable patient characteristics are associated with higher costs and are not accounted for in the payment formula, the DRG system already rewards hospitals for avoiding patients with these risk factors. On the other side of the issue, some stakeholders proposed substantial expansions of the list of nonreimbursable conditions, given the extent of injuries, the number of deaths, and the magnitude of the expense associated with patient-safety problems in hospitals; the approval of a much larger set of conditions would have ratcheted up the financial implications and made a more compelling case for more fundamental and comprehensive reform of inpatient care. In the end, however, CMS ruled out a number of candidate conditions, either because they could not be identified through existing DRG codes or because of a lack of proven strategies for preventing them.

In the same regulatory ruling, Medicare has also refined the DRG system to increase the extent of payment differentiation according to the severity of illness. Thus, along with emerging pay-for-performance initiatives, the new policy appears to be part of a larger reform of the Medicare payment scheme. The current reform rests on the following three principles: payers should pay more for the treatment of conditions that require more resources and that the provider could not reasonably have prevented; they should pay more when evidence-based or consensus-based best practices are followed; and they should pay less or not at all for low-quality care. Naturally, the last will be the most controversial.

The conditions for which Medicare will cease to pay hospitals as of next October have been shown to be within the control of hospitals, so there is a relatively compelling case that their costs should fall on the provider rather than the purchaser. It is unclear how Medicare will generalize the principle of refusal to pay for poor-quality care beyond this initial and largely symbolic effort. As inadequate as the store of evidence-based beneficial practices appears to advocates of pay for performance, there is even less empirical support or consensus for the identification of inappropriate or clearly contraindicated services and care patterns.

An interview with Dr. Rosenthal can be heard at www.nejm.org.

Source Information

Dr. Rosenthal is an associate professor of health economics and policy at the Harvard School of Public Health, Boston.

References

References

  1. 1

    Ball RM. What Medicare's architects had in mind. Health Aff (Millwood) 1995;14:62-72
    CrossRef | Web of Science | Medline

  2. 2

    Medicare program: changes to the hospital inpatient prospective payment systems and fiscal year 2008 rates. Fed Regist 2007;72:47379-47428

  3. 3

    Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica 1979;47:263-292
    CrossRef | Web of Science

Citing Articles (63)

Citing Articles

  1. 1

    John R. Downey, Tina Hernandez-Boussard, Gaurav Banka, John M. Morton. (2012) Is Patient Safety Improving? National Trends in Patient Safety Indicators: 1998-2007. Health Services Research 47:1pt2, 414-430
    CrossRef

  2. 2

    Julie D. Lankiewicz, Deborah S. Yokoe, Margaret A. Olsen, Fallon Onufrak, Victoria J. Fraser, Kurt Stevenson, Yosef Khan, David Hooper, Richard Platt, Susan S. Huang. (2012) Beyond 30 Days: Does Limiting the Duration of Surgical Site Infection Follow-up Limit Detection?. Infection Control and Hospital Epidemiology 33:2, 202-204
    CrossRef

  3. 3

    Oliver Anderson, Piers R Boshier, George B Hanna, Oliver Anderson. 2012. Interventions designed to prevent healthcare bed-related injuries in patients. .
    CrossRef

  4. 4

    Carley Riley, Derek S. Wheeler. (2012) Prevention of Sepsis in Children: A New Paradigm for Public Policy. Critical Care Research and Practice 2012, 1-8
    CrossRef

  5. 5

    Oliver Anderson, Piers Boshier, George Hanna, Oliver Anderson. 2011. Interventions designed to prevent healthcare bed-related injuries in patients. .
    CrossRef

  6. 6

    Ba' Pham, Laura Teague, James Mahoney, Laurie Goodman, Mike Paulden, Jeff Poss, Jianli Li, Luciano Ieraci, Steven Carcone, Murray Krahn. (2011) Early Prevention of Pressure Ulcers Among Elderly Patients Admitted Through Emergency Departments: A Cost-effectiveness Analysis. Annals of Emergency Medicine 58:5, 468-478.e3
    CrossRef

  7. 7

    Elizabeth McNamara, Derk Adams, Timothy H. Dellit. (2011) Improving central venous catheter insertion documentation to facilitate electronic surveillance of bundle compliance. American Journal of Infection Control 39:9, 779-781
    CrossRef

  8. 8

    Gavin Wardle, Walter P. Wodchis, Audrey Laporte, Geoffrey M. Anderson, G. Ross Baker. (2011) The Sensitivity of Adverse Event Cost Estimates to Diagnostic Coding Error. Health Services Researchn/a-n/a
    CrossRef

  9. 9

    Heather L. Evans, Keir Warner, Eileen M. Bulger, Sam R. Sharar, Ronald V. Maier, Joseph Cuschieri. (2011) Pre-Hospital Intubation Factors and Pneumonia in Trauma Patients. Surgical Infections 12:5, 339-344
    CrossRef

  10. 10

    Pieter Van Herck, Lieven Annemans, Delphine De Smedt, Roy Remmen, Walter Sermeus. (2011) Pay-for-performance step-by-step: Introduction to the MIMIQ model. Health Policy 102:1, 8-17
    CrossRef

  11. 11

    Thomas G. Weiser, Marcus E. Semel, Alan E. Simon, Stuart R. Lipsitz, Alex B. Haynes, Luke M. Funk, William R. Berry, Atul A. Gawande. (2011) In-hospital Death following Inpatient Surgical Procedures in the United States, 1996–2006. World Journal of Surgery 35:9, 1950-1956
    CrossRef

  12. 12

    Stijn Blot, Thiago Lisboa, Roser Angles, Jordi Rello. (2011) Prevention of VAP: Is Zero Rate Possible?. Clinics in Chest Medicine 32:3, 591-599
    CrossRef

  13. 13

    Ba’ Pham, Laura Teague, James Mahoney, Laurie Goodman, Mike Paulden, Jeff Poss, Jianli Li, Nancy Joan Sikich, Rosemarie Lourenco, Luciano Ieraci, Steven Carcone, Murray Krahn. (2011) Support surfaces for intraoperative prevention of pressure ulcers in patients undergoing surgery: A cost-effectiveness analysis. Surgery 150:1, 122-132
    CrossRef

  14. 14

    Andrew J. Lightfoot, Henry M. Rosevear, William D. Steers, Chad R. Tracy. (2011) Current and Future Need for Academic Urologists in the United States. The Journal of Urology 185:6, 2283-2287
    CrossRef

  15. 15

    William F. Bond, Arthur E. King. (2011) Modeling for the Decision Process to Implement an Educational Intervention. Journal of Patient Safety 7:2, 85-91
    CrossRef

  16. 16

    Joel A. Reyes, Michelle L. Habash, Richard P. Taylor. (2011) Femoral central venous catheters are not associated with higher rates of infection in the pediatric critical care population. American Journal of Infection Control
    CrossRef

  17. 17

    José Luis Navarro-Espigares, Elisa Hernández Torres. (2011) Efficiency and quality in health services: a crucial link. The Service Industries Journal 31:3, 385-403
    CrossRef

  18. 18

    Camille L Connelly, Michael T Archdeacon. (2011) Pulsatile lavage irrigator tip, a rare radiolucent retained foreign body in the pelvis: a case report. Patient Safety in Surgery 5:1, 14
    CrossRef

  19. 19

    Shayna E. Rich, David Margolis, Michelle Shardell, William G. Hawkes, Ram R. Miller, Sania Amr, Mona Baumgarten. (2011) Frequent manual repositioning and incidence of pressure ulcers among bed-bound elderly hip fracture patients. Wound Repair and Regeneration 19:1, 10-18
    CrossRef

  20. 20

    Jessica West, Yosef Khan, David M. Murray, Kurt B. Stevenson. (2010) Assessing specific secondary ICD-9-CM codes as potential predictors of surgical site infections. American Journal of Infection Control 38:9, 701-705
    CrossRef

  21. 21

    Rodney Johnson, Chitra Dinakar. (2010) Pediatric Pay-for-performance in Asthma: Who Pays?. Current Allergy and Asthma Reports 10:6, 405-410
    CrossRef

  22. 22

    Michael S. Niederman, Jeffrey T. Berger. (2010) The delivery of futile care is harmful to other patients. Critical Care Medicine 38, S518-S522
    CrossRef

  23. 23

    Jeffrey E. Nowak, Richard J. Brilli, Michael R. Lake, Karen W. Sparling, John Butcher, Marion Schulte, Derek S. Wheeler. (2010) Reducing catheter-associated bloodstream infections in the pediatric intensive care unit: Business case for quality improvement. Pediatric Critical Care Medicine 11:5, 579-587
    CrossRef

  24. 24

    Gina Berg, Sue Nyberg, Paul Harrison, Jessica Baumchen, Erin Gurss, Emily Hennes. (2010) Near-Infrared Spectroscopy Measurement of Sacral Tissue Oxygen Saturation in Healthy Volunteers Immobilized on Rigid Spine Boards. Prehospital Emergency Care 14:4, 419-424
    CrossRef

  25. 25

    Matthew D. Tipping, Victoria E. Forth, David B. Magill, Kate Englert, Mark V. Williams. (2010) Systematic Review of Time Studies Evaluating Physicians in the Hospital Setting. Journal of Hospital Medicine 5:6, 353-359
    CrossRef

  26. 26

    Mary Hersh, Meital Amir Nazarian. (2010) Palliative Care Can Help Reduce Incidence of Medicare's Never-Events for Dementia Patients. Journal of Hospice & Palliative Nursing 12:4, 247-254
    CrossRef

  27. 27

    Elizabeth Khaykin, Daniel E. Ford, Peter J. Pronovost, Lisa Dixon, Gail L. Daumit. (2010) National estimates of adverse events during nonpsychiatric hospitalizations for persons with schizophrenia. General Hospital Psychiatry 32:4, 419-425
    CrossRef

  28. 28

    Patricia W. Stone, Sherry A. Glied, Peter D. McNair, Nikolas Matthes, Bevin Cohen, Timothy F. Landers, Elaine L. Larson. (2010) CMS Changes in Reimbursement for HAIs. Medical Care 48:5, 433-439
    CrossRef

  29. 29

    Cassie M. Banks, Heather Gilmartin, Regina M. Fink. (2010) Education Methods for Maintaining Nursing Competency in Low-Volume, High-Risk Procedures in the Rural Setting. Journal for Nurses in Staff Development (JNSD) 26:3, E1-E7
    CrossRef

  30. 30

    S. Andrew Josephson, Asma M. Moheet, Michael A. Gropper, Amy D. Nichols, Wade S. Smith. (2010) Ventilator-Associated Pneumonia in a Neurologic Intensive Care Unit Does Not Lead to Increased Mortality. Neurocritical Care 12:2, 155-158
    CrossRef

  31. 31

    M. Baumgarten, D. Margolis, D. Orwig, W. Hawkes, S. Rich, P. Langenberg, M. Shardell, M. H. Palmer, P. McArdle, R. Sterling, P. S. Jones, J. Magaziner. (2010) Use of Pressure-Redistributing Support Surfaces Among Elderly Hip Fracture Patients Across the Continuum of Care: Adherence to Pressure Ulcer Prevention Guidelines. The Gerontologist 50:2, 253-262
    CrossRef

  32. 32

    Sara M. Bradley, Reena Karani, Thomas McGinn, Juan Wisnivesky. (2010) Predictors of serious injury among hospitalized patients evaluated for falls. Journal of Hospital Medicine 5:2, 63-68
    CrossRef

  33. 33

    Onno K. Helder, Jos M. Latour. (2010) Undergraduate nurse students' education in infection prevention: is it effective to change the attitude and compliance with hand hygiene?. Nursing in Critical Care 15:1, 39-40
    CrossRef

  34. 34

    William Riley. (2010) Interaction of Quality and Finance in the Intensive Care Unit. Clinical Pulmonary Medicine 17:1, 20-27
    CrossRef

  35. 35

    Rocco Ricciardi, Nancy N. Baxter, Thomas E. Read, Peter W. Marcello, David J. Schoetz, Patricia L. Roberts. (2009) Surgeon Involvement in the Care of Patients Deemed to Have “Preventable” Conditions. Journal of the American College of Surgeons 209:6, 707-711
    CrossRef

  36. 36

    Spencer D. Dorn. (2009) United States Health Care Reform in 2009: A Primer for Gastroenterologists. Clinical Gastroenterology and Hepatology 7:11, 1168-1173
    CrossRef

  37. 37

    Patricia W Stone. (2009) Economic burden of healthcare-associated infections: an American perspective. Expert Review of Pharmacoeconomics & Outcomes Research 9:5, 417-422
    CrossRef

  38. 38

    Peter Gliatto, Philip Masters, Reena Karani. (2009) Medical Student Documentation in the Medical Record: Is It a Liability?. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 76:4, 357-364
    CrossRef

  39. 39

    Milstein, Arnold, . (2009) Ending Extra Payment for “Never Events” — Stronger Incentives for Patients' Safety. New England Journal of Medicine 360:23, 2388-2390
    Full Text

  40. 40

    Kendra Rumbaugh. (2009) Should we be afraid of the Green Monster?*. Critical Care Medicine 37:5, 1826-1827
    CrossRef

  41. 41

    Mona Baumgarten, David J. Margolis, Denise L. Orwig, Michelle D. Shardell, William G. Hawkes, Patricia Langenberg, Mary H. Palmer, Patricia S. Jones, Patrick F. McArdle, Robert Sterling, Bruce P. Kinosian, Shayna E. Rich, Janice Sowinski, Jay Magaziner. (2009) Pressure Ulcers in Elderly Patients with Hip Fracture Across the Continuum of Care. Journal of the American Geriatrics Society 57:5, 863-870
    CrossRef

  42. 42

    Donald E. Fry, Michael Pine, Barbara L. Jones, Roger J. Meimban. (2009) Adverse outcomes in surgery: redefinition of postoperative complications. The American Journal of Surgery 197:4, 479-484
    CrossRef

  43. 43

    Mona Baumgarten, Michelle Shardell, Shayna Rich. (2009) Methodological Issues in Studies of the Effectiveness of Pressure Ulcer Prevention Interventions. Advances in Skin & Wound Care 22:4, 180-188
    CrossRef

  44. 44

    Elliott R. Haut, David C. Chang, Charles A. Pierce, Elizabeth Colantuoni, David T. Efron, Adil H. Haider, Edward E. Cornwell, Peter J. Pronovost. (2009) Predictors of Posttraumatic Deep Vein Thrombosis (DVT): Hospital Practice Versus Patient Factors—An Analysis of the National Trauma Data Bank (NTDB). The Journal of Trauma: Injury, Infection, and Critical Care 66:4, 994-1001
    CrossRef

  45. 45

    Shayna E. Rich, Michelle Shardell, David Margolis, Mona Baumgarten. (2009) Pressure Ulcer Preventive Device Use Among Elderly Patients Early in the Hospital Stay. Nursing Research 58:2, 95-104
    CrossRef

  46. 46

    Lisa I. Iezzoni. (2009) Reinvigorating the Quality Improvement Incentives of Hospital Prospective Payment. Medical Care 47:3, 269-271
    CrossRef

  47. 47

    Peter McNair, Daniel Borovnicar, Terri Jackson, Steve Gillett. (2009) Prospective Payment to Encourage System Wide Quality Improvement. Medical Care 47:3, 272-278
    CrossRef

  48. 48

    M. H. Scheetz, M. K. Bolon, M. Postelnick, G. A. Noskin, T. A. Lee. (2009) Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis. Journal of Antimicrobial Chemotherapy 63:4, 816-825
    CrossRef

  49. 49

    Kathleen Rauch, Jennifer Balascio, Penny Gilbert. (2009) Excellence in Action: Developing and Implementing a Fall Prevention Program. Journal for Healthcare Quality 31:1, 36-42
    CrossRef

  50. 50

    Chesley Richards. (2009) Getting to Zero: An Emerging Policy Framework for the Elimination of Hospital‐Associated Infections • . Infection Control and Hospital Epidemiology 30:1, 71-73
    CrossRef

  51. 51

    Thiago Lisboa, Donald E. Craven, Jordi Rello. (2009) Safety in Critical Care and Pulmonary Medicine. Clinical Pulmonary Medicine 16:1, 28-32
    CrossRef

  52. 52

    Barbara A. Mark, David W. Harless. (2009) Nurse staffing and post-surgical complications using the present on admission indicator. Research in Nursing & Healthn/a-n/a
    CrossRef

  53. 53

    Caprice C. Greenberg, Atul A. Gawande. (2008) Retained Foreign Bodies. Advances in Surgery 42, 183-191
    CrossRef

  54. 54

    Dimitri M Drekonja, Michael A Kuskowski, Timothy J Wilt, James R Johnson. (2008) Antimicrobial urinary catheters: a systematic review. Expert Review of Medical Devices 5:4, 495-506
    CrossRef

  55. 55

    JOAN M. STANLEY, JANE GANNON, JESSE GABUAT, SUSAN HARTRANFT, NANCY ADAMS, CHRISTY MAYES, GINA M. SHOUSE, BARBARA A. EDWARDS, DANITA BURCH. (2008) The clinical nurse leader: a catalyst for improving quality and patient safety. Journal of Nursing Management 16:5, 614-622
    CrossRef

  56. 56

    Thiago Lisboa, Marin H. Kollef, Jordi Rello. (2008) Prevention of VAP: the whole is more than the sum of its parts. Intensive Care Medicine 34:6, 985-987
    CrossRef

  57. 57

    Ellen T. Kurtzman, Peter I. Buerhaus. (2008) New Medicare Payment Rules. AJN, American Journal of Nursing 108:6, 30-35
    CrossRef

  58. 58

    Ronald I. Shorr, Lorraine C. Mion, A. Michelle Chandler, Linda C. Rosenblatt, Debra Lynch, Lori A. Kessler. (2008) Improving the Capture of Fall Events in Hospitals: Combining a Service for Evaluating Inpatient Falls with an Incident Report System. Journal of the American Geriatrics Society 56:4, 701-704
    CrossRef

  59. 59

    Kurt B. Stevenson, Yosef Khan, Jeanne Dickman, Terri Gillenwater, Pat Kulich, Carol Myers, David Taylor, Jennifer Santangelo, Jennifer Lundy, David Jarjoura, Xiaobai Li, Janice Shook, Julie E. Mangino. (2008) Administrative coding data, compared with CDC/NHSN criteria, are poor indicators of health care–associated infections. American Journal of Infection Control 36:3, 155-164
    CrossRef

  60. 60

    Giuseppe Lippi, Gérard Siest, Mario Plebani. (2008) Pharmacy-based laboratory services: past or future and risk or opportunity?. Clinical Chemistry and Laboratory Medicine 46:4, 435-436
    CrossRef

  61. 61

    S. Andrew Josephson, John W. Engstrom, Robert M. Wachter. (2008) Neurohospitalists: An emerging model for inpatient neurological care. Annals of Neurology 63:2, 135-140
    CrossRef

  62. 62

    E.M. Copeland. (2008) Nonpayment for Performance? Medicare's New Reimbursement Rule. Yearbook of Surgery 2008, 17-19
    CrossRef

  63. 63

    Jacyntha A. Sterling. (2007) Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy. Hospital Pharmacy 42:12, 1172-1175
    CrossRef